Drug Research
Treating brain disorders with new nanoparticle drug delivery system
A new nanoparticle drug-delivery system could help scientists overcome the long-standing problem of delivering therapeutics across the blood-brain barrier and into the brain.
Progress has been made over the past few decades in identifying biological pathways that lead to neurodegenerative...
News
Forge Biologics receives US FDA approval to initiate phase 1/2 trial of AAV gene therapy, FBX-101 to treat Krabbe disease
Forge Biologics Inc., a gene therapy manufacturing and development company, announced that the company has received FDA clearance of the Investigational New Drug (IND) to initiate a phase 1/2 clinical trial evaluating its novel, first-in-human AAV gene therapy, FBX-101,...
Drug Research
Pfizer, OPKO One Step Closer to Approval of Pediatric Growth Hormone Deficiency Drug
Pfizer and OPKO Health are one step closer to receiving approval for their jointly developed pediatric growth hormone deficiency (GHD) drug, somatrogon, after the U.S. FDA recently accepted the companies’ regulatory submission for the therapy.
The FDA accepted for filing...
Drug Research
Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Israel’s Ministry of Health (MOH) has given authorization to import the COVID-19 Vaccine Moderna in Israel.
“Today’s authorization is a landmark moment in our company’s history...
News
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that preliminary top-line data from its U.S. Phase 2 study with orally-administered opaganib (Yeliva®, ABC294640)1 in patients hospitalized with COVID-19 pneumonia demonstrated positive safety and efficacy signals.
The randomized, double-blind, placebo-controlled U.S....
News
CEPI Partners with Biological E. Limited to advance Development and Manufacture of COVID-19 Vaccine candidate
CEPI, the Coalition for Epidemic Preparedness Innovationsand Biological E Limited, India (Bio E), a Hyderabad-based vaccines and pharmaceutical company, today announced a collaboration to advance the development and manufacture of Bio E’s COVID-19 subunit vaccine candidate. CEPI will initially...
News
COVAXINTM – India’s First indigenous COVID-19 Vaccine
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















